HEMATOLOGICAL MALIGNANCY

This study is for people with blood cancers like leukemia who are getting chemotherapy or a stem cell transplant, which can cause very low white blood cell counts (neutropenia) for over a week. The goal is to see if the antibiotic eravacycline can prevent serious bacterial infect…

This study tests a stem cell transplant using a half-matched (haploidentical) donor for people with blood cancers who don't have a fully matched donor. The approach uses chemotherapy and radiation before transplant, plus drugs like cyclophosphamide and bortezomib after to prevent…

This study tests a new treatment using specially engineered natural killer (NK) cells from donated cord blood. The cells are designed to target a protein called CD5 found on certain blood cancer cells. About 64 people with relapsed or hard-to-treat blood cancers will receive thes…

This study looks at whether a tailored exercise program can help older blood cancer survivors slow down the aging process. Researchers will enroll 180 people aged 50 and older who have had blood cancer. The goal is to see if participants can stick with the exercise plan and if it…

This study aims to find specific genetic changes in the tumors of 10,000 adults with advanced solid or blood cancers. By analyzing tumor DNA and immune markers, researchers hope to match each patient with a targeted drug or clinical trial that may work best for their unique cance…

This study collects blood and bone marrow samples from 50 adults with blood cancer to learn more about a protein called DPP4. Researchers hope this will help them understand how the cancer grows and find better treatments. Participants will not receive any experimental therapy.

This study tests whether cancer patients getting chemotherapy can use an Apple Watch and iPhone app to track their health from home. About 100 adults with solid tumors or blood cancers will wear the watch and use the app during treatment. The goal is to see if patients can use th…